World Health Organization classified corona virus disease 2019 (COVID-19) as a pandemic, at the time of writing affecting nearly every country and territory across the globe. During this time global healthcare systems struggling with shortages of personal protective equipments, ventilators and supportive medical equipments. Patients with COVID-19 are at risk for acute respiratory distress syndrome (ARDS) and other complications especially in patients with co-morbidity like diabetes, chronic kidney disease, patient on cancer chemotherapy and a fraction will require high-level respiratory support to survive. Additionally, significant strain has been placed on protective equipment like face mask, face shields, Personal protective kit, uninterrupted supplies of which, required to protect the healthcare workers helping to treat critically ill patients during this pandemic. During this time of exigency 3D printing health care manufacturing technology is pivotal, as this is not only robust, economical and accurate but also versatile and useful for various applications. 3D printing is a revolutionary healthcare manufacturing technique which can transform three dimensional designs into real objects. 3D printing technology has innumerable applications in the field of healthcare and education where it has introduced customization, prototyping, manufacturing and personalization. Although innovative yet, 3D printed and bioprinted products still face many challenges including a proper legal status, quality assurance, intellectual property rights as well as safety of end users. There is an urgent need to establish in-depth guidelines so that such an innovative and miraculous technique can support mankind and strained health care systems.